Free Trial

Oppenheimer Asset Management Inc. Increases Stock Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

U.S. Physical Therapy logo with Medical background

Oppenheimer Asset Management Inc. increased its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 15.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,588 shares of the company's stock after acquiring an additional 3,464 shares during the quarter. Oppenheimer Asset Management Inc. owned about 0.17% of U.S. Physical Therapy worth $1,852,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of USPH. CBIZ Investment Advisory Services LLC boosted its position in shares of U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after purchasing an additional 122 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in U.S. Physical Therapy in the fourth quarter worth about $39,000. Lazard Asset Management LLC acquired a new stake in U.S. Physical Therapy in the fourth quarter worth about $84,000. Fifth Third Bancorp grew its stake in shares of U.S. Physical Therapy by 34.6% during the first quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock worth $75,000 after acquiring an additional 265 shares during the last quarter. Finally, Aquatic Capital Management LLC grew its stake in shares of U.S. Physical Therapy by 18.0% during the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock worth $115,000 after acquiring an additional 198 shares during the last quarter.

Insiders Place Their Bets

In related news, Director Nancy Ham sold 400 shares of the firm's stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $78.01, for a total transaction of $31,204.00. Following the completion of the sale, the director now directly owns 2,594 shares in the company, valued at approximately $202,357.94. This trade represents a 13.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 2.00% of the company's stock.

Analysts Set New Price Targets

USPH has been the topic of a number of research reports. William Blair reissued a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. JPMorgan Chase & Co. decreased their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Wednesday, March 19th. Barrington Research dropped their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. JMP Securities reiterated a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Finally, Wall Street Zen raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, U.S. Physical Therapy has an average rating of "Moderate Buy" and an average target price of $109.00.

Read Our Latest Stock Report on U.S. Physical Therapy

U.S. Physical Therapy Price Performance

USPH traded up $0.44 during trading on Friday, hitting $79.13. The company's stock had a trading volume of 409,680 shares, compared to its average volume of 120,531. The firm has a market capitalization of $1.20 billion, a price-to-earnings ratio of 36.30, a P/E/G ratio of 3.80 and a beta of 1.45. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $101.20. The business's fifty day simple moving average is $74.66 and its 200 day simple moving average is $80.18. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.32.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, topping analysts' consensus estimates of $0.46 by $0.02. The business had revenue of $183.79 million during the quarter, compared to analysts' expectations of $176.78 million. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. The company's quarterly revenue was up 18.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.51 earnings per share. On average, equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Friday, May 23rd were paid a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.27%. The ex-dividend date was Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio is currently 82.57%.

U.S. Physical Therapy Company Profile

(Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

See Also

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Should You Invest $1,000 in U.S. Physical Therapy Right Now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines